We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+23.79%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$340M
AUM Growth
-$5.31M
(-1.5%)
Cap. Flow
-$28M
Cap. Flow
% of AUM
-8.22%
Top 10 Holdings %
Top 10 Hldgs %
23.05%
Holding
889
New
138
Increased
211
Reduced
255
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$10.1M |
| 2 |
Vale
VALE
|
+$2.39M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.33M |
| 4 |
Coca-Cola
KO
|
+$2.2M |
| 5 |
Wells Fargo
WFC
|
+$1.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$13.6M |
| 2 |
iShares MSCI Turkey ETF
TUR
|
+$7.85M |
| 3 |
iShares MSCI Taiwan ETF
EWT
|
+$6.97M |
| 4 |
Logitech
LOGI
|
+$5.93M |
| 5 |
UBS Group
UBS
|
+$5.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.54% |
| 2 | Consumer Discretionary | 15.45% |
| 3 | Healthcare | 13.48% |
| 4 | Technology | 13.47% |
| 5 | Financials | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Axsome Therapeutics
AXSM
$10.7B
| $347K | 0.1% |
4,258
+3,015
| +243% | +$225K |
|
|
FLIR
227
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $344K | 0.1% |
7,845
+5,409
| +222% | +$209K |
|
|
FAX
228
abrdn Asia-Pacific Income Fund
FAX
$570M
| $343K | 0.1% |
12,834
| – | – |
|
229
First Solar
FSLR
$21.7B
| $339K | 0.1% |
+3,427
| New | +$297K |
|
230
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.2B
| $337K | 0.1% |
2,906
-73
| -2% | -$8.27K |
|
231
Enbridge
ENB
$106B
| $337K | 0.1% |
10,534
| – | – |
|
232
EnerSys
ENS
$6.15B
| $334K | 0.1% |
4,025
+3,363
| +508% | +$264K |
|
233
lululemon athletica
LULU
$10.9B
| $330K | 0.1% |
947
+943
| +23,575% | +$327K |
|
234
iShares Gold Trust
IAU
$63.7B
| $323K | 0.09% |
+8,900
| New | +$319K |
|
235
Chevron
CVX
$427B
| $322K | 0.09% |
3,811
-14,979
| -80% | -$1.21M |
|
|
236
PUT
Stellantis
STLA
$14.8B
| $317K | 0.09% |
1,482
-13,785
| -90% | -$203K |
|
237
iShares Russell 2000 ETF
IWM
$76.9B
| $313K | 0.09% |
1,599
-1,350
| -46% | -$236K |
|
238
Uber
UBER
$146B
| $313K | 0.09% |
6,145
-222
| -3% | -$9.95K |
|
239
Gilead Sciences
GILD
$181B
| $312K | 0.09% |
5,349
-15,592
| -74% | -$941K |
|
240
Philip Morris
PM
$303B
| $312K | 0.09% |
3,763
+715
| +23% | +$55.7K |
|
241
Stryker
SYK
$108B
| $307K | 0.09% |
1,252
-2,123
| -63% | -$481K |
|
242
Kodiak Sciences
KOD
$2.07B
| $305K | 0.09% |
2,076
-491
| -19% | -$54.7K |
|
|
JMIA
243
Jumia Technologies
JMIA
$977M
| $303K | 0.09% |
+7,500
| New | +$183K |
|
244
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.1B
| $303K | 0.09% |
2,190
-8,232
| -79% | -$1.12M |
|
245
Acadia Pharmaceuticals
ACAD
$4.61B
| $294K | 0.09% |
5,505
+2,580
| +88% | +$128K |
|
246
Norwegian Cruise Line
NCLH
$6.56B
| $294K | 0.09% |
11,553
+886
| +8% | +$18.5K |
|
247
Vicor
VICR
$8.48B
| $293K | 0.09% |
+3,179
| New | +$267K |
|
248
Cooper Companies
COO
$10.1B
| $291K | 0.09% |
3,208
-3,052
| -49% | -$262K |
|
249
ConocoPhillips
COP
$170B
| $290K | 0.09% |
7,259
-4,617
| -39% | -$170K |
|
250
SolarEdge
SEDG
$2.17B
| $290K | 0.09% |
+909
| New | +$251K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2020 Portfolio in Review
As of Q4 2020, Exane Derivatives held 889 positions worth $340M, down 1.5% from $345M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Exane Derivatives withdrew a net $28M in Q4 2020, closing 64 positions and reducing 255 holdings. Its most notable exit was ProShares S&P 500 Dividend Aristocrats ETF, an estimated $2.55M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Exane Derivatives opened a new position in Vale worth $3.01M.
- Exane Derivatives's largest Q4 2020 buy was Vale: 179,430 shares worth $3.01M.
- Exane Derivatives added most to Stellantis in Q4 2020, an estimated $10.1M increase.
- Exane Derivatives's biggest Q4 2020 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $13.6M.
- Exane Derivatives fully exited ProShares S&P 500 Dividend Aristocrats ETF in Q4 2020, selling an estimated $2.55M.
- Exane Derivatives's ten largest holdings make up 23% of its $340M portfolio in Q4 2020.
- Exane Derivatives opened 138 new positions and closed 64 in Q4 2020.
- Exane Derivatives's portfolio value fell 1.5% quarter-over-quarter to $340M.
Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.